Julie-Aurore Losman, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Purpura Fulminans | 2 | 2024 | 21 | 1.540 |
Why?
|
Isocitrate Dehydrogenase | 7 | 2024 | 937 | 1.400 |
Why?
|
Glutarates | 6 | 2024 | 243 | 1.330 |
Why?
|
Ketoglutaric Acids | 1 | 2020 | 75 | 0.700 |
Why?
|
Dioxygenases | 2 | 2020 | 345 | 0.690 |
Why?
|
Leukemia | 3 | 2022 | 1518 | 0.670 |
Why?
|
Protein C | 1 | 2018 | 133 | 0.620 |
Why?
|
Perforin | 1 | 2018 | 166 | 0.610 |
Why?
|
Thrombomodulin | 1 | 2018 | 105 | 0.600 |
Why?
|
Molecular Targeted Therapy | 3 | 2018 | 2813 | 0.570 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2024 | 2820 | 0.550 |
Why?
|
Procollagen-Proline Dioxygenase | 2 | 2013 | 81 | 0.520 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2018 | 269 | 0.480 |
Why?
|
Myeloproliferative Disorders | 2 | 2017 | 609 | 0.390 |
Why?
|
Glioma | 3 | 2023 | 3452 | 0.380 |
Why?
|
Mutation | 7 | 2024 | 30006 | 0.360 |
Why?
|
Sepsis | 1 | 2024 | 2586 | 0.340 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2023 | 3609 | 0.340 |
Why?
|
Neoplasms | 3 | 2024 | 22125 | 0.270 |
Why?
|
Histone Demethylases | 2 | 2023 | 322 | 0.220 |
Why?
|
Hematopoiesis | 1 | 2013 | 2046 | 0.220 |
Why?
|
Receptors, Complement | 1 | 2024 | 254 | 0.220 |
Why?
|
Butyrate Response Factor 1 | 1 | 2022 | 10 | 0.210 |
Why?
|
Oncogenes | 3 | 2017 | 1220 | 0.180 |
Why?
|
Citric Acid Cycle | 1 | 2020 | 231 | 0.160 |
Why?
|
Capnocytophaga | 1 | 2018 | 26 | 0.160 |
Why?
|
Receptors, Interleukin-4 | 1 | 1999 | 64 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15915 | 0.160 |
Why?
|
Signal Transduction | 5 | 2017 | 23415 | 0.150 |
Why?
|
Cell Hypoxia | 1 | 2020 | 656 | 0.150 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13630 | 0.150 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2019 | 173 | 0.150 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2022 | 423 | 0.140 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2018 | 167 | 0.140 |
Why?
|
Histone Code | 1 | 2018 | 158 | 0.140 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 619 | 0.140 |
Why?
|
E-Selectin | 1 | 2018 | 577 | 0.130 |
Why?
|
Endothelium | 1 | 2018 | 763 | 0.130 |
Why?
|
Interleukin-4 | 2 | 2002 | 1154 | 0.130 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2017 | 430 | 0.120 |
Why?
|
Calreticulin | 1 | 2016 | 113 | 0.120 |
Why?
|
Repressor Proteins | 3 | 2022 | 2974 | 0.120 |
Why?
|
Receptors, Thrombopoietin | 1 | 2016 | 160 | 0.120 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2018 | 1032 | 0.120 |
Why?
|
Retinoblastoma Protein | 1 | 2018 | 671 | 0.120 |
Why?
|
Amino Acid Substitution | 1 | 2018 | 1737 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 448 | 0.110 |
Why?
|
Histones | 1 | 2023 | 2570 | 0.100 |
Why?
|
Reactive Oxygen Species | 1 | 2020 | 2138 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2002 | 2870 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 2022 | 3700 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1790 | 0.100 |
Why?
|
Catalysis | 1 | 2013 | 763 | 0.090 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20981 | 0.090 |
Why?
|
DNA Damage | 1 | 2020 | 2443 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3790 | 0.090 |
Why?
|
Alleles | 2 | 2018 | 6857 | 0.090 |
Why?
|
Humans | 17 | 2024 | 761098 | 0.090 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1323 | 0.080 |
Why?
|
DNA Methylation | 1 | 2023 | 4386 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3594 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4189 | 0.060 |
Why?
|
Animals | 10 | 2024 | 168083 | 0.060 |
Why?
|
Neurodegenerative Diseases | 1 | 2014 | 1085 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2018 | 2331 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5662 | 0.060 |
Why?
|
Cell Line, Tumor | 3 | 2019 | 16947 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-pim-1 | 2 | 2002 | 32 | 0.050 |
Why?
|
Anticoagulants | 1 | 2018 | 4795 | 0.050 |
Why?
|
Salicylanilides | 1 | 2022 | 15 | 0.050 |
Why?
|
STAT6 Transcription Factor | 2 | 2002 | 196 | 0.050 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 2 | 2002 | 178 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2014 | 2021 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2019 | 11505 | 0.050 |
Why?
|
Models, Biological | 2 | 2013 | 9455 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2022 | 9025 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2018 | 9566 | 0.040 |
Why?
|
Disease Progression | 1 | 2017 | 13506 | 0.040 |
Why?
|
Prospective Studies | 1 | 2024 | 54419 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2018 | 3577 | 0.040 |
Why?
|
Oncogene Proteins v-abl | 1 | 1998 | 19 | 0.040 |
Why?
|
Cell Line | 5 | 2016 | 15542 | 0.040 |
Why?
|
Pyrimidines | 2 | 2022 | 3026 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2019 | 363 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 2 | 2002 | 4510 | 0.040 |
Why?
|
Genes, Retinoblastoma | 1 | 2018 | 125 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13382 | 0.040 |
Why?
|
Phosphotransferases | 1 | 1999 | 303 | 0.040 |
Why?
|
Interleukin-3 | 1 | 1998 | 425 | 0.040 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2019 | 249 | 0.040 |
Why?
|
Carrier Proteins | 2 | 2002 | 4933 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2012 | 5781 | 0.040 |
Why?
|
Triazoles | 1 | 2022 | 903 | 0.030 |
Why?
|
Heart Septal Defects | 1 | 2018 | 190 | 0.030 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1999 | 412 | 0.030 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 1999 | 557 | 0.030 |
Why?
|
Structure Collapse | 1 | 2016 | 4 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 1999 | 1429 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11732 | 0.030 |
Why?
|
Mice | 7 | 2022 | 81324 | 0.030 |
Why?
|
Integrases | 1 | 2018 | 518 | 0.030 |
Why?
|
STAT Transcription Factors | 1 | 2016 | 188 | 0.030 |
Why?
|
Janus Kinases | 1 | 2016 | 248 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1822 | 0.030 |
Why?
|
Transgenes | 1 | 2018 | 1008 | 0.030 |
Why?
|
Frameshift Mutation | 1 | 2016 | 392 | 0.030 |
Why?
|
Mice, SCID | 1 | 2019 | 2621 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2022 | 1855 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 2 | 2018 | 3725 | 0.030 |
Why?
|
Tamoxifen | 1 | 2018 | 965 | 0.030 |
Why?
|
Translocation, Genetic | 1 | 2019 | 1391 | 0.030 |
Why?
|
Trans-Activators | 2 | 2002 | 2846 | 0.030 |
Why?
|
Mice, Nude | 2 | 2014 | 3604 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2018 | 64670 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2012 | 193 | 0.020 |
Why?
|
Protein Binding | 3 | 2016 | 9300 | 0.020 |
Why?
|
Cell Division | 1 | 1998 | 4451 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1999 | 2443 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1998 | 2426 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2016 | 2692 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4137 | 0.020 |
Why?
|
Echocardiography | 1 | 2018 | 5006 | 0.020 |
Why?
|
Female | 3 | 2019 | 392458 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6198 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12404 | 0.020 |
Why?
|
Middle Aged | 1 | 2018 | 220835 | 0.010 |
Why?
|
Adult | 1 | 2018 | 221083 | 0.010 |
Why?
|
Astrocytes | 1 | 2012 | 1341 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2016 | 3388 | 0.010 |
Why?
|
Apoptosis | 1 | 2019 | 9478 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12096 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3598 | 0.010 |
Why?
|
Transfection | 2 | 2002 | 5750 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2002 | 812 | 0.010 |
Why?
|
Two-Hybrid System Techniques | 1 | 2002 | 460 | 0.010 |
Why?
|
Heart | 1 | 2014 | 4431 | 0.010 |
Why?
|
Male | 1 | 2018 | 360675 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 711 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2002 | 565 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22129 | 0.010 |
Why?
|
Gene Library | 1 | 2002 | 1055 | 0.010 |
Why?
|
Janus Kinase 1 | 1 | 1998 | 107 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 1989 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16572 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9416 | 0.010 |
Why?
|
Thymus Gland | 1 | 2002 | 1243 | 0.010 |
Why?
|
Plasmids | 1 | 2002 | 2261 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18217 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2002 | 4168 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10421 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1998 | 1225 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1998 | 1751 | 0.010 |
Why?
|
Phosphorylation | 1 | 2002 | 8303 | 0.010 |
Why?
|
Binding Sites | 1 | 1998 | 5993 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2002 | 12743 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1998 | 11856 | 0.000 |
Why?
|
Time Factors | 1 | 2002 | 39953 | 0.000 |
Why?
|